SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes? SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes?

Real-world study finds heart failure hospitalization reduction compared to metformin but not MI, stroke, or overall mortality, and greater genital infection risk.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news